MDxHealth (MDXH) Set to Announce Earnings on Wednesday

MDxHealth (NASDAQ:MDXH) is set to post its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect MDxHealth to post earnings of ($0.28) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

MDxHealth (NASDAQ:MDXH) last announced its quarterly earnings results on Wednesday, August 21st. The company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.05). MDxHealth had a negative net margin of 50.54% and a negative return on equity of 987.86%. The company had revenue of $22.16 million during the quarter, compared to the consensus estimate of $20.66 million. On average, analysts expect MDxHealth to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

MDxHealth Trading Down 1.9 %

Shares of NASDAQ:MDXH opened at $2.04 on Tuesday. The business’s fifty day moving average price is $2.35 and its two-hundred day moving average price is $2.60. MDxHealth has a fifty-two week low of $1.95 and a fifty-two week high of $4.64.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital initiated coverage on MDxHealth in a research note on Thursday, October 31st. They set a “buy” rating and a $7.00 price target on the stock.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.